Short Chain Fatty Acids: Microbial Metabolites with Clinical Impact

Short-chain fatty acids (SCFAs) — principally butyrate, propionate, and acetate — are the primary metabolic products of colonic fermentation of dietary fiber and represent the most important functional link between the microbiome and host physiology. Their clinical significance extends far beyond gut health, with established roles in immune regulation, metabolic homeostasis, and neurobiology.

Production and Microbial Sources

Butyrate is produced primarily by Faecalibacterium prausnitzii, Roseburia intestinalis, Butyrivibrio fibrisolvens, and Eubacterium rectale. Propionate is produced by Bacteroidetes and some Firmicutes. Acetate — the most abundant SCFA — is a cross-feeding substrate for butyrate producers and is produced broadly across many taxa. Total SCFA production in a healthy colon is 300-400 mmol/day.

Butyrate: The Colonocyte Fuel

Colonocytes derive 70% of their energy from butyrate via beta-oxidation. This dependency makes butyrate availability a direct determinant of colonocyte viability, tight junction integrity, and mucus secretion. Butyrate also:

• Inhibits NF-κB and histone deacetylase (HDAC), reducing inflammatory gene expression
• Induces regulatory T cell (Treg) differentiation via FOXP3 expression
• Enhances mucin production (MUC2) and tight junction proteins (claudin-1, ZO-1)
• Suppresses colon cancer cell proliferation and induces apoptosis in vitro

Propionate and Metabolic Regulation

Propionate is transported to the liver via portal circulation where it suppresses cholesterol synthesis (HMG-CoA reductase inhibition) and serves as a gluconeogenic substrate. It also activates FFAR2/3 receptors on enteroendocrine cells, stimulating PYY and GLP-1 secretion — contributing to satiety and glucose regulation. The metabolic effects of propionate link the microbiome directly to insulin sensitivity and appetite control.

Clinical Implications of SCFA Deficiency

Reduced SCFA production — resulting from low-fiber diet, antibiotic use, or loss of butyrate-producing bacteria — is associated with IBD, colorectal cancer, insulin resistance, and neuroinflammation. Restoration strategies: high-fiber diet (>30g/day), resistant starch supplementation, targeted supplementation with butyrate-producing strains, and direct butyrate supplementation (sodium butyrate 4g/day). See our articles on diet and the microbiome and F. prausnitzii.